Clinical Trials on Gaucher Disease, Type I in Netherlands

Total 2045 results

University of Groningen

Withdrawn

Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)

Complex Regional Pain Syndrome Type I of the Upper Limb

Netherlands
University Medical Center Groningen
Ultragenyx Pharmaceutical Inc

Completed

Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia (ENGLUPRO GSDIa)

Glycogen Storage Disease Type IA

Netherlands
Prothya Biosolutions

Completed

Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

Hereditary Angioedema Type I | Angioneurotic Edema

Netherlands
Ultragenyx Pharmaceutical Inc

Completed

Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa

Glycogen Storage Disease Type IA

Netherlands, United States
Sanofi

Completed

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

Diabetes, Type I

Germany, Netherlands, France
Stichting Achmea Slachtoffer en Samenleving

Completed

Prophylactic Administration of Vitamin C in Wrist Fractures

RSD (Reflex Sympathetic Dystrophy) | Algodystrophy | CRPS Type I

Netherlands
Actelion

Completed

Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease

Gaucher Disease Type 1

United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
Erasmus Medical Center

Unknown

The Cognitive Variability in NF1 and TSC Monozygotic Twins (COVANTT)

Tuberous Sclerosis Complex | Neurofibromatosis Type I

Netherlands
Maastricht University Medical Center
Maastricht University

Completed

Neurophysiological Basis of Rehabilitation in Complex Regional Pain Syndrome, Type I and Chronic Low Back Pain (BrainEXPain)

Chronic Pain

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1) (PEPTOC)

Complex Regional Pain Syndrome, Type I

Netherlands
Novartis Pharmaceuticals

Terminated

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Familial Chylomicronemia Syndrome (FCS) (HLP Type I)

South Africa, Germany, United Kingdom, France, United States, Canada, Netherlands
Orchard Therapeutics

Recruiting

A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT (HURCULES)

MPS-IH (Hurler Syndrome)

Netherlands, United States, Italy, United Kingdom
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and III

Netherlands, Australia, Belgium
Erasmus Medical Center

Not yet recruiting

Studying Topiramate for Re-Activating the HIV-1 Reservoir (STAR)

HIV Infections | Hiv | HIV-1-infection | HIV I Infection

Netherlands
Maastricht University Medical Center

Completed

Prevention of Sacral Pressure Ulcers With Preventive Dressings (SACRESS)

Grade I to Grade IV Pressure Ulcers in Higher Risk Patients

Netherlands
Ultragenyx Pharmaceutical Inc

Active, not recruiting

Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia

Glycogen Storage Disease Type IA | Von Gierke's Disease (GSD Type Ia)

Netherlands, United States, Canada, Spain
Maastricht University

Not yet recruiting

Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II

Lung Cancer Stage I | Lung Cancer Stage II

Netherlands
Amedica Corporation

Completed

Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion SNAP Trial (SNAP)

Degenerative Spondylolisthesis | Disc Degeneration of Pfirrmann Grade III or Greater | Isthmic Spondylolisthesis of Grade I or II

Netherlands
Leiden University Medical Center
Andaluz Health Service

Completed

"POWER2DM Evaluation Campaign" (POWER2DMEC)

Diabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

Netherlands, Spain
Maastricht Radiation Oncology

Completed

Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

Stage I-III Small Cell Lung Cancer

Netherlands
Radboud University Medical Center
HypoResolve

Unknown

Current State of Impaired Awareness of Hypoglycaemia in People With Type 1 Diabetes

Diabetes type1

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

Stage I-III Non-small Cell Lung Cancer

Netherlands
The Netherlands Cancer Institute
Dutch Cancer Society

Terminated

Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis (HALO)

Lung Metastases | Lung Cancer Stage I | Lung Cancer Stage II

Netherlands
KalVista Pharmaceuticals, Ltd.

Completed

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Hereditary Angioedema

United States, Austria, Czechia, Germany, Hungary, Italy, Netherlands, North Macedonia, Poland, United Kingdom
Pharvaris Netherlands B.V.

Completed

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (RAPIDe-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

Bulgaria, United States, Spain, Israel, Germany, Canada, Czechia, France, Hungary, Italy, Netherlands, Poland, United Kingdom
Ultragenyx Pharmaceutical Inc

Active, not recruiting

A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)

Glycogen Storage Disease Type IA

United States, Brazil, Canada, Denmark, Germany, Italy, Netherlands, Spain
Cees Tack

Not yet recruiting

Role of Adrenaline in in the Inflammatory Response in Diabetes (RAID)

Hypoglycemia | Diabetes type1 | Inflammatory Response

Netherlands
Academisch Ziekenhuis Maastricht
European Foundation for the Study of Diabetes

Completed

Light Intensity Physical Activity Trial (LiPAT)

Diabetes Mellitus | Physical Activity | Sedentary Lifestyle | Type2 Diabetes | Aortic Stiffness | Arterial Stiffness | Physical Exercise | Pulse Wave Velocity | Light Intensity Physical Activity | Artery Disease

Netherlands
M.H.H. Kramer

Active, not recruiting

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES (RACELINES)

Type2 Diabetes

Netherlands
University Hospital, Essen

Recruiting

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NEOpredict)

NSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIA

Belgium, Germany, Netherlands
Maastricht University Medical Center

Unknown

Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes (NO troponin)

Type 2 Diabetes Mellitus

Netherlands
Hoffmann-La Roche

Completed

A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477

Healthy Volunteer, Type 2 Diabetes

Netherlands
UMC Utrecht

Completed

Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.

Type 2 Diabetes Mellitus

Netherlands
DiaMedica Therapeutics Inc

Completed

A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

Diabetes Type 2

Netherlands
Maastricht University Medical Center

Completed

Vinegar Co-ingestion in Type 2 Diabetes

Type 2 Diabetes Mellitus

Netherlands
Radboud University Medical Center
European Foundation for the Study of Diabetes; Dutch Diabetes Research Foundation

Completed

The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia

Type 1 Diabetes Mellitus With Hypoglycemia

Netherlands
Japan Tobacco Inc.

Completed

Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia

Type II Hyperlipidaemia

Netherlands
Radboud University Medical Center

Not yet recruiting

The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device (GATE)

Diabetes Mellitus Type 2 in Obese

Netherlands
Maastricht University Medical Center
European Foundation for the Study of Diabetes; Netherlands Organisation for...

Completed

Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes

Type 2 Diabetes

Netherlands
Maastricht University Medical Center
Novo Nordisk A/S

Completed

SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2 (SIT LESS 2)

Type 2 Diabetes

Netherlands
Maastricht University Medical Center
Alpro Foundation

Completed

Dietary Polyphenols and Lipid Oxidation

Obesity, Insulin Sensitivity, Type 2 Diabetes Mellitus

Netherlands
Leiden University Medical Center
Radboud University Medical Center; Health Holland; Dutch Kidney Foundation

Completed

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. (Glycotreat)

Glucose Metabolism Disorders | Kidney Diseases | Diabetes Mellitus | Diabetic Nephropathies | Albuminuria | Microalbuminuria | Type2 Diabetes Mellitus | Diabetic Nephropathy Type 2 | Diabetic Complications Renal | South Asian

Netherlands
Radboud University Medical Center

Completed

Vildagliptin and Endothelium-dependent Vasodilatation

Type 2 Diabetes | Endothelial Dysfunction

Netherlands
Amsterdam UMC, location VUmc

Completed

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. (ROCKIES)

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Diabetic Kidney Disease | Renal Hypoxia | Renoprotection | SGLT2 Inhibitor | Ertugliflozin

Netherlands
Erasmus Medical Center
Utrecht University

Unknown

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex (RAPIT)

Tuberous Sclerosis Complex | TSC Related Cognitive Disability | TSC Related Autism | TSC Related Learning Problems

Netherlands
Amsterdam UMC, location VUmc
EU FP7: SAFEGUARD consortium

Completed

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Type 2 Diabetes

Netherlands
TNO

Recruiting

Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes (2DIAREM)

Type 2 Diabetes

Netherlands
Amsterdam UMC, location VUmc

Completed

Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals (PEAKS)

Type 2 Diabetes Mellitus

Netherlands
Radboud University Medical Center

Terminated

Beta Cell Imaging in T1D Patients With a Different Glycemic Control (GLP1-reg)

Type 1 Diabetes Mellitus

Netherlands
Radboud University Medical Center

Unknown

Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes (ELEGANT)

Type 2 Diabetes Mellitus

Netherlands

Clinical Trials on Gaucher Disease, Type I in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations